Study finds under-representation of certain populations in cancer clinical trials

study finds under representation of certain populations in cancer clinical trials

Sumary of Study finds under-representation of certain populations in cancer clinical trials:

  • In a study examining disparities and trends in the inclusion of minorities, women, and older patients in cancer clinical trials, investigators found that certain populations remain under-represented.
  • However, for some, including Black and Hispanic patients, participation has increased in recent years.
  • By including people from diverse backgrounds, clinical trials can show if treatments are safe and effective for people with different characteristics.
  • The National Cancer Institute (NCI) has established multiple initiatives to encourage such diversity in the clinical trials it funds.
  • The researchers compared clinical trial participation from 2015–2019 to the proportion of cancer incidence rates from 2015–2017 for non-Hispanic whites versus minorities, elderly versus nonelderly patients, and female versus male patients.
  • In these comparisons of trial participation with cancer incidence rates, Black and Hispanic patients were more likely to participate in breast cancer clinical trials, but were under-represented in colorectal, lung, and prostate cancer trials;

Want to know more click here go to source.

From -


Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.